From reducing treatment times to making cancer care more accessible, subcutaneous drug delivery is changing the cancer treatment landscape.

AI consumed conversations as expected, but conversations are getting more nuanced. The annual event also revealed more anxiety about pressing problems.

Healthcare AI is developing at a rapid rate, and the industry’s attitude on how to best regulate and deploy this technology is evolving every day, according to leaders attending this year’s ViVE conference.

Launched from the Mayo Clinic Accelerator Program, the medical search platform uses AI to aggregate medical research.

Dr. Halamka spoke at ViVE about the need for AI in health care, starting small and moving fast, weighing risks, and a future when not[...]

As the U.S. braces for a dearth of physicians and nurses, healthcare organizations are transforming processes to attract and retain talent.

In a video, Mayo Clinic oncology care providers say subcutaneous drug delivery for cancer patients not only shortens treatment time but also improves compliance, reduces[...]

As artificial intelligence and other digital health technologies make their mark, provider organizations need to pursue "organizational ambidexterity." Here's what that means, along with six[...]

Mayo Clinic Health System is driving growth and digital transformation with a focus on improving patient experience through AI and automation, including Mayo Clinic Platform,[...]

John Halamka, M.D., president of Mayo Clinic Platform, emphasized in a recent interview the need for pragmatism in AI adoption in healthcare, urging CIOs to[...]

Technology and hospital-at-home programs are paving the way for in-home treatments to be the new frontier in cancer care — if reimbursement and other challenges can be worked out.